Literature DB >> 11478509

H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor?

G Holtmann1, J Gschossmann, M Holtmann, N J Talley.   

Abstract

The relationship between H. pylori and functional dyspepsia is controversial. Hypothesizing that subjects with a more intense immune response to H. pylori (and hence higher antibody titers) would be at greater risk of dyspepsia, we aimed to identify risk factors for the development of dyspeptic symptoms. In all, 491 healthy blood donors with no history of peptic ulceration and 74 consecutive patients with a confirmed diagnosis of functional dyspepsia were studied. Symptoms and potential risk factors [nonsteroidal antiinflammatory drugs (NSAIDs), alcohol, and smoking] were measured by a validated questionnaire. H. pylori status was determined by IgG antibodies using a validated ELISA test with a cutoff titer for a positive serology of 10 units/ml. Logistic regression analysis assessed the association between risk factors and dyspepsia. Among blood donors, 21% (95% CI 17.6-24.8) reported dyspepsia (pain localized to the upper abdomen); 7.7% (95% CI 5.5-10.4) had frequent dyspepsia (>6 times in the prior year). The age-adjusted prevalence of H. pylori was not significantly different in blood donors with (39.5%, 95% CI 24.0-56.6) and without frequent dyspepsia (34.2%, 95% CI 29.8-38.36), but was significantly greater in patients with functional dyspepsia (68.8%, 95% CI 57.3-77.9). In the combined study population of blood donors and patients with functional dyspepsia, logistic regression adjusting for age identified the following independent risk factors for frequent dyspepsia: high serum antibody levels against H. pylori (OR for IgG titer >50 units/ml vs H. pylori titers 11-50 units/ml 4.6, 95% CI 2.7-7.8) and consumption of standard NSAIDs (OR 2.4,95% CI 1.3-4.5). In contrast, alcohol (OR 0.6, 95% CI 0.3-1.0), smoking (OR 1.5, 95% CI 1.0-2.3) or positive H. pylori serology with titers < or = 50 units/ml (OR 1.6, 95% CI 0.8-2.9) were not associated with frequent dyspepsia. In conclusion, in a subgroup of H. pylori-infected subjects who have high antibody titers, H. pylori appears to be associated with functional dyspepsia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478509     DOI: 10.1023/a:1010612509593

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

Authors:  K McColl; L Murray; E El-Omar; A Dickson; A El-Nujumi; A Wirz; A Kelman; C Penny; R Knill-Jones; T Hilditch
Journal:  N Engl J Med       Date:  1998-12-24       Impact factor: 91.245

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

Authors:  N J Talley; N Vakil; E D Ballard; M B Fennerty
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

4.  Manometric evaluation of functional upper gut symptoms.

Authors:  J R Malagelada; V Stanghellini
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

5.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Prevalence of peptic ulcer in Helicobacter pylori positive blood donors.

Authors:  D Vaira; M Miglioli; P Mulè; J Holton; M Menegatti; M Vergura; G Biasco; R Conte; R P Logan; L Barbara
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

7.  Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone.

Authors:  M Bradette; P Pare; P Douville; A Morin
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

Review 8.  Virulence and pathogenicity of Helicobacter pylori.

Authors:  B J Marshall
Journal:  J Gastroenterol Hepatol       Date:  1991 Mar-Apr       Impact factor: 4.029

9.  Functional bowel disorders in apparently healthy people.

Authors:  W G Thompson; K W Heaton
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

10.  Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia.

Authors:  G Holtmann; H Goebell; J Talley
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

View more
  4 in total

1.  Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia.

Authors:  G Holtmann; N J Talley; H Goebell
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

2.  Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori.

Authors:  Giovanni Sarnelli; Rosario Cuomo; Jozef Janssens; Jan Tack
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

3.  Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders.

Authors:  W Ajaj; S C Goehde; N Papanikolaou; G Holtmann; S G Ruehm; J F Debatin; T C Lauenstein
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 4.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.